{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:15:57Z","timestamp":1781777757546,"version":"3.54.5"},"reference-count":62,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvascsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jvs.2020.04.525","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T20:30:59Z","timestamp":1591993859000},"page":"2186-2196.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access"],"prefix":"10.1016","volume":"72","author":[{"given":"Xiyang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niten","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne W.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2020.04.525_bib1","first-page":"715","article-title":"Drug-coated balloons for complex femoropopliteal lesions: 2-year results of a real-world registry","volume":"9","author":"Schmidt","year":"2016","journal-title":"JACC: Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.04.525_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa0706356","article-title":"Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg","volume":"358","author":"Tepe","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.04.525_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ejvs.2018.02.001","article-title":"Editor's choice\u2014vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)","volume":"55","author":"Schmidli","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"Suppl 3","key":"10.1016\/j.jvs.2020.04.525_bib4","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 10","key":"10.1016\/j.jvs.2020.04.525_bib5","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.5301\/jva.5000426","article-title":"Percutaneous transluminal angioplasty in Japan: five-center investigation","volume":"16","author":"Murakami","year":"2015","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jvs.2020.04.525_bib6","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/j.ajkd.2013.02.351","article-title":"Canadian Society of Nephrology guidelines for the management of patients with ESRD treated with intensive hemodialysis","volume":"62","author":"Nesrallah","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2020.04.525_bib7","doi-asserted-by":"crossref","first-page":"e0172798","DOI":"10.1371\/journal.pone.0172798","article-title":"Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model","volume":"12","author":"Izuhara","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jvs.2020.04.525_bib8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jvir.2019.01.012","article-title":"Drug-coated balloon angioplasty in hemodialysis circuits: a systematic review and meta-analysis","volume":"30","author":"Kennedy","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/nep.13591","article-title":"Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up","volume":"24","author":"Phang","year":"2019","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jvs.2020.04.525_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/1129729818793102","article-title":"Treatment of juxta-anastomotic stenoses for failing distal radiocephalic arteriovenous fistulas: drug-coated balloons versus angioplasty","volume":"20","author":"Patan\u00e8","year":"2019","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jvs.2020.04.525_bib11","doi-asserted-by":"crossref","first-page":"e011245","DOI":"10.1161\/JAHA.118.011245","article-title":"Risk of death following application of paclitaxel-coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Katsanos","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jvs.2020.04.525_bib12","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1016\/j.jacc.2019.01.013","article-title":"Mortality not correlated with paclitaxel exposure: an independent patient-level meta-analysis of a drug-coated balloon","volume":"73","author":"Schneider","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib13","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00270-019-02171-3","article-title":"The efficacy of paclitaxel drug-eluting balloon angioplasty versus standard balloon angioplasty in stenosis of native hemodialysis arteriovenous fistulas: an analysis of clinical success, primary patency and risk factors for recurrent dysfunction","volume":"42","author":"Yildiz","year":"2019","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/1129729818801556","article-title":"Multicentre, randomised, blinded, control trial of drug-eluting balloon vs sham in recurrent native dialysis fistula stenoses","volume":"20","author":"Swinnen","year":"2019","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jvs.2020.04.525_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.jvs.2020.04.525_bib16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jvs.2020.04.525_bib17","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jvs.2020.04.525_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"10.1016\/j.jvs.2020.04.525_bib19","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1177\/0284185119838173","article-title":"Treatment of restenosis in radiocephalic arteriovenous hemodialysis fistulas: percutaneous transluminal angioplasty or drug-coated balloon","volume":"60","author":"Haave","year":"2019","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/1457496918798206","article-title":"Drug-coated versus plain balloon angioplasty in arteriovenous fistulas: a randomized, controlled study with 1-year follow-up (the Drecorest Ii-study)","volume":"108","author":"Bjorkman","year":"2019","journal-title":"Scand J Surg"},{"key":"10.1016\/j.jvs.2020.04.525_bib21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.2215\/CJN.14231217","article-title":"Drug coated balloon angioplasty in failing AV fistulas: a randomized controlled trial","volume":"13","author":"Trerotola","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2020.04.525_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jvir.2017.10.023","article-title":"Multicenter, randomized trial of conventional balloon angioplasty versus paclitaxel-coated balloon angioplasty for the treatment of dysfunctioning autologous dialysis fistulae","volume":"29","author":"Maleux","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib23","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00270-018-1942-z","article-title":"Endovascular treatment of haemodialysis arteriovenous fistula with drug-coated balloon angioplasty: a single-centre study","volume":"41","author":"Lu\u010dev","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1148\/radiol.2018170806","article-title":"Hemodialysis arteriovenous fistula and graft stenoses: randomized trial comparing drug-eluting balloon angioplasty with conventional angioplasty","volume":"289","author":"Irani","year":"2018","journal-title":"Radiology"},{"key":"10.1016\/j.jvs.2020.04.525_bib25","doi-asserted-by":"crossref","first-page":"35","DOI":"10.23736\/S1824-4777.17.01282-7","article-title":"Paclitaxel-coated balloons do not prevent recurrent stenosis in hemodialysis access fistulae: results of a randomized clinical trial","volume":"24","author":"Roosen","year":"2017","journal-title":"Ital J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2020.04.525_bib26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jvir.2017.03.007","article-title":"Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial","volume":"28","author":"Kitrou","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib27","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s11604-016-0577-8","article-title":"The primary patency of drug-eluting balloon versus conventional balloon angioplasty in hemodialysis patients with arteriovenous fistula stenoses","volume":"34","author":"\u00c7ilda\u011f","year":"2016","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib28","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/1526602814566907","article-title":"Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas","volume":"22","author":"Massmann","year":"2015","journal-title":"J\u00a0Endovasc Ther"},{"key":"10.1016\/j.jvs.2020.04.525_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jvir.2014.11.003","article-title":"Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial","volume":"26","author":"Kitrou","year":"2015","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib30","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ejrad.2014.11.037","article-title":"Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472)","volume":"84","author":"Kitrou","year":"2015","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib31","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jvir.2013.12.014","article-title":"Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study","volume":"25","author":"Lai","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib32","first-page":"S229","article-title":"Interim analysis of the DEBAPTA trial: a randomized trial comparing drug-eluting balloon angioplasty versus conventional percutaneous transluminal angioplasty for treatment of hemodialysis arteriovenous fistula or arteriovenous graft stenoses","volume":"36","author":"Teo","year":"2013","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1583\/11-3690.1","article-title":"Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial","volume":"19","author":"Katsanos","year":"2012","journal-title":"J\u00a0Endovasc Ther"},{"issue":"Suppl 1","key":"10.1016\/j.jvs.2020.04.525_bib34","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US Renal Data System 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2020.04.525_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ndt\/gfv427","article-title":"Chronic kidney disease prevalence in the general population: heterogeneity and concerns","volume":"31","author":"De Nicola","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jvs.2020.04.525_bib36","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.2015050542","article-title":"CKD prevalence varies across the European General Population","volume":"27","author":"Bruck","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2020.04.525_bib37","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1681\/ASN.2005050615","article-title":"Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint","volume":"17","author":"Roy-Chaudhury","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.jvs.2020.04.525_bib38","first-page":"e19","article-title":"Drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis\u2014a systematic review and meta-analysis","volume":"17","author":"Khawaja","year":"2016","journal-title":"J\u00a0Vasc Access"},{"key":"10.1016\/j.jvs.2020.04.525_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/00015458.2018.1561796","article-title":"Paclitaxel drug-coated balloon angioplasty for the treatment of failing arteriovenous fistulas: a single-center experience","volume":"120","author":"Yazar","year":"2020","journal-title":"Acta Chir Belg"},{"key":"10.1016\/j.jvs.2020.04.525_bib40","doi-asserted-by":"crossref","first-page":"59","DOI":"10.23736\/S0392-9590.17.03886-X","article-title":"Drug-coated balloons reduce the risk of recurrent restenosis in arteriovenous fistulas and prosthetic grafts for hemodialysis","volume":"37","author":"Troisi","year":"2018","journal-title":"Int Angiol"},{"key":"10.1016\/j.jvs.2020.04.525_bib41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcin.2011.03.005","article-title":"Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program","volume":"4","author":"Stone","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jvs.2020.04.525_bib42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11239-014-1091-4","article-title":"Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials","volume":"39","author":"De Luca","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jvs.2020.04.525_bib43","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/bs.podrm.2018.11.001","article-title":"Paclitaxel","volume":"44","author":"Alqahtani","year":"2019","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"10.1016\/j.jvs.2020.04.525_bib44","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1161\/01.CIR.96.2.636","article-title":"Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in\u00a0vitro and in\u00a0vivo using local drug delivery","volume":"96","author":"Axel","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2020.04.525_bib45","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2165\/00003088-199427040-00002","article-title":"Clinical pharmacokinetics of paclitaxel","volume":"27","author":"Sonnichsen","year":"1994","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jvs.2020.04.525_bib46","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.addr.2017.05.015","article-title":"The Lutonix drug-coated balloon: a novel drug delivery technology for the treatment of vascular disease","volume":"112","author":"Schorn","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.jvs.2020.04.525_bib47","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000091346","article-title":"Development of a local perivascular paclitaxel delivery system for hemodialysis vascular access dysfunction: polymer preparation and in\u00a0vitro activity","volume":"24","author":"Melhem","year":"2006","journal-title":"Blood Purif"},{"key":"10.1016\/j.jvs.2020.04.525_bib48","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvs.2020.04.525_bib49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.amsu.2016.08.019","article-title":"Weekly paclitaxel therapy for gastric cancer in patients with renal dysfunction: a case report","volume":"11","author":"Kanematsu","year":"2016","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.jvs.2020.04.525_bib50","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1684\/bdc.2011.1489","article-title":"[Anticancer drugs management in renal insufficiency patients]","volume":"99","author":"Zimmer-Rapuch","year":"2012","journal-title":"Bull Cancer"},{"key":"10.1016\/j.jvs.2020.04.525_bib51","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1525-1438.2007.01048.x","article-title":"High dose single-agent paclitaxel in a hemodialysis patient with advanced ovarian cancer: a case report with pharmacokinetic analysis and review of the literature","volume":"18","author":"Baur","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.jvs.2020.04.525_bib52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lab.2004.06.002","article-title":"Arterial and venous smooth-muscle cells differ in their responses to antiproliferative drugs","volume":"144","author":"Kim","year":"2004","journal-title":"J\u00a0Lab Clin Med"},{"key":"10.1016\/j.jvs.2020.04.525_bib53","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jcb.20903","article-title":"Different signaling responses to anti-proliferative agents in human aortic and venous smooth muscle cells","volume":"99","author":"Lee","year":"2006","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.jvs.2020.04.525_bib54","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jvs.2013.09.006","article-title":"Impact of severe chronic kidney disease on outcomes of infrainguinal peripheral arterial intervention","volume":"59","author":"Patel","year":"2014","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.525_bib55","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.semvascsurg.2015.01.006","article-title":"The impact of chronic renal insufficiency on vascular surgery patient outcomes","volume":"27","author":"Nathan","year":"2014","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.525_bib56","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0033-0620(96)80022-3","article-title":"New stent technologies","volume":"39","author":"Ozaki","year":"1996","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jvs.2020.04.525_bib57","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(14)60384-6","article-title":"Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure","volume":"383","author":"Ortiz","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2020.04.525_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.avsg.2015.04.092","article-title":"Mortality and cost of acute and chronic kidney disease after vascular surgery","volume":"30","author":"Huber","year":"2016","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jvs.2020.04.525_bib59","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1053\/j.ajkd.2018.01.006","article-title":"Chapter 3: morbidity and mortality in patients with CKD","volume":"71","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jvs.2020.04.525_bib60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ehjqcco\/qcw057","article-title":"Long-term survival and fate of the leg in de novo intermittent claudication","volume":"3","author":"Kumakura","year":"2017","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.jvs.2020.04.525_bib61","doi-asserted-by":"crossref","first-page":"45833","DOI":"10.1038\/srep45833","article-title":"The fate of patients with intermittent claudication in the 21st century revisited\u2014results from the CAVASIC study","volume":"8","author":"Rantner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvs.2020.04.525_bib62","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jcin.2018.02.019","article-title":"Drug-coated balloon treatment of femoropopliteal lesions for patients with intermittent claudication and ischemic rest pain: 2-year results from the IN.PACT Global Study","volume":"11","author":"Micari","year":"2018","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420313173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521420313173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:30:13Z","timestamp":1760041813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521420313173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0741521420313173"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2020.04.525","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvs.2020.04.525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}